Cargando…
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
INTRODUCTION: Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR-α-tocopherol ether-linked acetic acid analogue (α-TEA) is a small bioactive lipid with potent anticancer act...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326562/ https://www.ncbi.nlm.nih.gov/pubmed/22115051 http://dx.doi.org/10.1186/bcr3063 |
_version_ | 1782229530944995328 |
---|---|
author | Tiwary, Richa Yu, Weiping deGraffenried, Linda A Sanders, Bob G Kline, Kimberly |
author_facet | Tiwary, Richa Yu, Weiping deGraffenried, Linda A Sanders, Bob G Kline, Kimberly |
author_sort | Tiwary, Richa |
collection | PubMed |
description | INTRODUCTION: Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR-α-tocopherol ether-linked acetic acid analogue (α-TEA) is a small bioactive lipid with potent anticancer activity. We evaluated the ability of α-TEA in the presence of tamoxifen to circumvent TAMR in human breast cancer cell lines. METHODS: Two genotypically matched sets of TAM-sensitive (TAMS) and TAM-resistant (TAMR) human breast cancer cell lines were assessed for signal-transduction events with Western blotting, apoptosis induction with Annexin V-FITC/PI assays, and characterization of cholesterol-rich microdomains with fluorescence staining. Critical involvement of selected mediators was determined by using RNA interference and chemical inhibitors. RESULTS: Growth-factor receptors (total and phosphorylated forms of HER-1 and HER-2), their downstream prosurvival mediators pAkt, pmTOR, and pERK1/2, phosphorylated form of estrogen receptor-α (pER-α at Ser-167 and Ser-118, and cholesterol-rich lipid microdomains were highly amplified in TAMR cell lines and enhanced by treatment with TAM. α-TEA disrupted cholesterol-rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators, and induced DR5-mediated mitochondria-dependent apoptosis via an endoplasmic reticulum stress-triggered pro-death pJNK/CHOP/DR5 amplification loop. Furthermore, methyl-β-cyclodextrin (MβCD), a chemical disruptor of cholesterol rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators and to induce apoptosis. CONCLUSIONS: Data for the first time document that targeting cholesterol-rich lipid microdomains is a potential strategy to circumvent TAMR, and the combination of α-TEA + TAM can circumvent TAMR by suppression of prosurvival signaling via disruption of cholesterol-rich lipid microdomains and activation of apoptotic pathways via induction of endoplasmic reticulum stress. |
format | Online Article Text |
id | pubmed-3326562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33265622012-04-16 Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer Tiwary, Richa Yu, Weiping deGraffenried, Linda A Sanders, Bob G Kline, Kimberly Breast Cancer Res Research Article INTRODUCTION: Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR-α-tocopherol ether-linked acetic acid analogue (α-TEA) is a small bioactive lipid with potent anticancer activity. We evaluated the ability of α-TEA in the presence of tamoxifen to circumvent TAMR in human breast cancer cell lines. METHODS: Two genotypically matched sets of TAM-sensitive (TAMS) and TAM-resistant (TAMR) human breast cancer cell lines were assessed for signal-transduction events with Western blotting, apoptosis induction with Annexin V-FITC/PI assays, and characterization of cholesterol-rich microdomains with fluorescence staining. Critical involvement of selected mediators was determined by using RNA interference and chemical inhibitors. RESULTS: Growth-factor receptors (total and phosphorylated forms of HER-1 and HER-2), their downstream prosurvival mediators pAkt, pmTOR, and pERK1/2, phosphorylated form of estrogen receptor-α (pER-α at Ser-167 and Ser-118, and cholesterol-rich lipid microdomains were highly amplified in TAMR cell lines and enhanced by treatment with TAM. α-TEA disrupted cholesterol-rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators, and induced DR5-mediated mitochondria-dependent apoptosis via an endoplasmic reticulum stress-triggered pro-death pJNK/CHOP/DR5 amplification loop. Furthermore, methyl-β-cyclodextrin (MβCD), a chemical disruptor of cholesterol rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators and to induce apoptosis. CONCLUSIONS: Data for the first time document that targeting cholesterol-rich lipid microdomains is a potential strategy to circumvent TAMR, and the combination of α-TEA + TAM can circumvent TAMR by suppression of prosurvival signaling via disruption of cholesterol-rich lipid microdomains and activation of apoptotic pathways via induction of endoplasmic reticulum stress. BioMed Central 2011 2011-11-24 /pmc/articles/PMC3326562/ /pubmed/22115051 http://dx.doi.org/10.1186/bcr3063 Text en Copyright ©2011 Tiwary et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tiwary, Richa Yu, Weiping deGraffenried, Linda A Sanders, Bob G Kline, Kimberly Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer |
title | Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer |
title_full | Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer |
title_fullStr | Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer |
title_full_unstemmed | Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer |
title_short | Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer |
title_sort | targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326562/ https://www.ncbi.nlm.nih.gov/pubmed/22115051 http://dx.doi.org/10.1186/bcr3063 |
work_keys_str_mv | AT tiwaryricha targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer AT yuweiping targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer AT degraffenriedlindaa targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer AT sandersbobg targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer AT klinekimberly targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer |